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Cutaneous RANK–RANKL Signaling Upregulates
CD8-Mediated Antiviral Immunity during Herpes
simplex Virus Infection by Preventing Virus-Induced
Langerhans Cell Apoptosis
Lars Klenner1,2, Wali Hafezi3, Björn E. Clausen4, Eva U. Lorentzen5, Thomas A. Luger1, Stefan Beissert1,6,
Joachim E. Kühn3 and Karin Loser1,2,7,8
Herpes simplex virus-type 1 (HSV-1) causes the majority of cutaneous viral infections. Viral infections are
controlled by the immune system, and CD8+ cytotoxic T-lymphocytes (CTLs) have been shown to be crucial
during the clearance of HSV-1 infections. Although epidermal Langerhans cells (LCs) are the ﬁrst dendritic cells
(DCs) to come into contact with the virus, it has been shown that the processing of viral antigens and the
differentiation of antiviral CTLs are mediated by migratory CD103+ dermal DCs and CD8α+ lymph node–resident
DCs. In vivo regulatory T-cells (Tregs) are implicated in the regulation of antiviral immunity and we have shown
that signaling via the receptor activator of NF-κB (RANK) and its ligand RANKL mediates the peripheral expansion
of Tregs. However, in addition to expanding Tregs, RANK–RANKL interactions are involved in the control of
antimicrobial immunity by upregulating the priming of CD4+ effector T cells in LCMV infection or by the
generation of parasite-speciﬁc CD8+ T cells in Trypanosoma cruzi infection. Here, we demonstrate that
cutaneous RANK–RANKL signaling is critical for the induction of CD8-mediated antiviral immune responses
during HSV-1 infection of the skin by preventing virus-induced LC apoptosis, improving antigen transport to
regional lymph nodes, and increasing the CTL priming capacity of lymph node DCs.
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INTRODUCTION
Herpes simplex virus infection is still one of the major causes
of morbidity in immunocompromised individuals, and under-
standing the mechanisms underlying protective antiviral
immunity is central to the development of therapies or
vaccines. Herpes simplex virus type 1 or type 2 (HSV-1 or
HSV-2) infects skin as well as the mucosal epithelium. During
cutaneous infection, HSV-1 undergoes several rounds of local
replication, subsequently enters sensory nerve endings, and
travels to the neural ganglia by retrograde axonal transport,
where it replicates and is able to persist as a latent infection
(Bedoui et al., 2009; Egan et al., 2013; Roizman and Whitley,
2013). Cutaneous HSV-1 infections are characterized by two
phases of viral replication in the skin; a primary phase, limited
to the site of scariﬁcation (day 2 to day 4 post infection), and a
secondary phase from day 5 post infection involving the
entire innervated dermatome (Bedoui et al., 2009). Similar to
humans, in mouse models of HSV-1 infection also the
inoculated virus is known to migrate from the skin to the
dorsal root ganglia and to re-emerge via retroaxonal transport
along the sensory ﬁbers, resulting in a band-like or zosteriform
region of vesiculating lesions spreading around the site of
primary infection (van Lint et al., 2004).
Among various immune cells that have been implicated in
the control of HSV-1 infections, CD8+ cytotoxic T lympho-
cytes (CTLs) are capable of clearing established infections
from the skin as well as from nerves and are critically involved
in limiting the viral spreading after epicutaneous infection
(van Lint et al., 2004; Zhu et al., 2013). Upon cutaneous
HSV-1 infection, efﬁcient priming of CTLs and rapid recruit-
ment to lesional skin is initiated by cutaneous dendritic cells
(DCs), like epidermal Langerhans cells (LCs) or dermal DCs,
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Figure 1. Reduced skin lesion size and decreased HSV-1 replication in K14-RANKL TG mice. (a) Skin lesion size of WT and K14-RANKL TG mice after
epicutaneous HSV-1 infection (n⩾17). (b and c) Representative photographs of skin pathology (b) and immunoﬂuorescence staining (c) of mock-infected
contralateral skin (c.s.) at day 8 as well as HSV-1-infected skin from WT and K14-RANKL TG mice at indicated time points post infection. Original magniﬁcation
×200, bar=50 μm. Results of statistical analysis of HSV-1-positive area from infected skin of n=5 mice in each group (c). (d) Quantitative real-time PCR of UL54
expression in lesional skin at days 2, 4, 8, and 13 post infection (n⩾3). (e) Immunoﬂuorescence staining of mock-infected contralateral skin (c.s.) at day 8 as well
as HSV-1-infected skin from WT and K14-RANKL TG mice at indicated time points post infection. Original magniﬁcation × 200, bar=50 μm. All the data are
shown as mean± SEM; *Po0.05 versus HSV-1-infected WT.
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which capture HSV-1 antigens, migrate to regional lymph
nodes, and stimulate the clonal expansion and differentiation
of antigen-speciﬁc CTLs (Davey et al., 2010; Bedoui and
Greyer, 2014). Interestingly, although LCs are the primary
cutaneous antigen-acquiring cells it has been shown that
lymph node–resident DCs but not LCs induce MHC class
I-restricted antiviral immunity and the priming of HSV-1-
speciﬁc CTLs (Allan et al., 2003; Cunningham et al., 2008;
Bedoui et al., 2009), most likely because HSV-1-infected LCs
appeared to be compromised in their trafﬁcking ability as they
failed to downregulate E-cadherin or undergo apoptosis after
HSV-1 infection (Bosnjak et al., 2005; Eidsmo et al., 2009;
Cunningham et al., 2010; Puttur et al., 2010).
In vivo cellular antiviral immune responses, such as the
induction and expansion of HSV-1-speciﬁc CTLs, are
controlled by immunosuppressive CD4+CD25+Foxp3+ reg-
ulatory T cells (Tregs). However, the precise role of Treg
during infection has been discussed controversially. Some
studies suggested that Tregs might impair protective antiviral
immunity (Lund et al., 2008), whereas others showed that
these cells minimized tissue damage (Belkaid et al., 2002;
Rouse and Suvas, 2007). In the skin, signaling via the receptor
activator of NF-κB (RANK) and its ligand (RANKL) is crucial
for the peripheral expansion of Tregs, as shown in a mouse
model with epidermal RANKL overexpression (K14-RANKL
TG mice) (Loser et al., 2006). However, in addition to
expanding immunosuppressive Tregs, RANK–RANKL
interactions have an important role during the induction of
antimicrobial immunity as antibody-mediated blocking of
RANK–RANKL signals diminished the priming of CD4+
effector T cells in lymphocytic choriomeningitis virus infec-
tions (Bachmann et al., 1999), whereas the administration of
soluble RANKL protein markedly enhanced the induction of
Trypanosoma cruzi-speciﬁc CD8+ effector T cells (Miyahira
et al., 2003). Thus, the role of RANK–RANKL signaling during
infection is not completely clear, and here we show that
epidermal RANKL is critical for the induction of antiviral
CD8+ effector T cells during HSV-1 infection of the skin by
preventing virus-induced apoptosis of LCs leading to an
enhanced antigen transport to regional lymph nodes and an
increased potency of lymph node–resident DCs to expand
virus-speciﬁc CTLs.
RESULTS
Reduced skin lesion size and decreased HSV-1 replication in
K14-RANKL TG mice
To investigate the role of RANK–RANKL signaling during
cutaneous viral infections, we epicutaneously infected the
back skin of K14-RANKL TG mice and wild-type (WT)
controls with 2× 107 plaque-forming units of the HSV-1
strain 17 syn+. Although mock-infected skin showed only
symptoms of mild inﬂammation, HSV-1 infection induced
erythema and scurfy, zosteriform skin disease starting at day 4
post infection (Figures 1a–d). Interestingly, HSV-1-induced
skin manifestations were better controlled in K14-RANKL TG
compared with WT mice as evidenced by the signiﬁcantly
reduced skin lesion severity (Figures 1a and b). Moreover, the
expression of virus proteins (Figure 1c) and virus replication,
as quantiﬁed by the expression of the HSV-1-speciﬁc
immediate-early gene UL54 encoding the infected cell protein
27 (ICP27) (Sandri-Goldin, 2011), was markedly decreased in
K14-RANKL TG versus WT skin (Figures 1c and d), thus
potentially suggesting a role of RANK–RANKL signaling
during the induction of antiviral immune responses. Of note,
HSV-1 infection upregulated RANKL (Figure 1e), which, as
expected, was more pronounced in TG compared with WT
skin and is in line with our previous observations showing an
increased RANKL expression upon skin inﬂammation (Loser
et al., 2006). However, epidermal RANKL overexpression did
not alter the levels of its receptor RANK as we detected similar
amounts in HSV-1-infected skin from WT and TG mice
(Figure 1e).
HSV-1 infection does not modulate cutaneous RANKL
overexpression, susceptibility of keratinocytes, or peripheral
expansion of Tregs in TG mice
Next, we assessed the numbers and function of Tregs in
infected mice to exclude an impact of cutaneous HSV-1
infection on the epidermal RANKL overexpression or the
RANKL-induced expansion of Tregs. As shown in
Supplementary Figure S1 online, HSV-1 infection of TG mice
neither affected RANKL overexpression in basal keratinocytes
(Supplementary Figure S1a online) nor reduced Treg numbers
or modulated their suppressive activity (Supplementary Figure
S1b and c online).
Skin infection initiates a cascade of wound-healing events,
including the release of various growth factors and cytokines
(Werner and Grose, 2003). To rule out whether cutaneous
RANKL overexpression might upregulate wound healing in
TG mice, we quantiﬁed the mRNA levels of characteristic
wound healing factors in HSV-1-infected skin. However, the
expression of these growth factors was similar in both groups
(Supplementary Figure S2a online), indicating that an
improved wound healing might not account for the reduced
skin lesion size in TG compared with WT mice. To investigate
whether RANKL overexpression in keratinocytes might
modulate their susceptibility toward HSV-1 infection, we
infected isolated keratinocytes from WT or K14-RANKL TG
epidermis with HSV-1. Twenty-four hours later, progeny virus
released into culture supernatants was quantiﬁed, and as shown
in Supplementary Figure S2b online, we detected a similar
infection rate in both groups. Likewise, the expression of surface
markers associated with the entry of HSV-1 into keratinocytes,
such as herpes virus entry mediator (Salameh et al., 2012;
Petermann et al., 2015), was comparable in keratinocytes from
WT and TG skin (Supplementary Figure S2c online).
Increased numbers of virus-speciﬁc CD8+ effector T cells in
K14-RANKL TG mice
Protective immunity to HSV-1 requires both the innate and
adaptive immune system. In particular, during the early phase
of infection, natural killer cells or Gr-1+ cells have been
implicated in limiting viral spread (Nandakumar et al., 2008;
Wojtasiak et al., 2010). To assess whether ampliﬁed innate
antiviral immune responses might account for the reduced
skin lesion development in K14-RANKL TG mice, we
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quantiﬁed the numbers of natural killer cells and Gr-1+ cells
at different time points after HSV-1 infection. However, cell
numbers, the expression of cytolytic molecules, and innate or
pro-inﬂammatory cytokines, as well as chemokines known to
attract innate immune cells such as neutrophils to HSV-1
lesions were similar in WT and TG mice (Supplementary
Figure S3a–c online). Moreover, HSV-1 infection of K14-
RANKL TG mice on a RAG1− /− background resulted in a
similar clinical phenotype and a comparable HSV-1 replica-
tion in lesional skin as compared with RAG1− /− controls
(Supplementary Figure S3d and e online), suggesting a minor
impact of cutaneous RANK–RANKL signaling on innate
HSV-1-speciﬁc antiviral immune responses.
However, we detected signiﬁcantly increased numbers of
CD8+ T cells in lymph nodes draining cutaneous lesions from
HSV-1-infected K14-RANKL TG compared with WT mice.
Notably, these CD8+ T cells showed an upregulated
expression of characteristic markers associated with cytolytic
activity, such as killer cell lectin-like receptor subfamily G
member 1 (KLRG1), IFN-γ, NKG2D (natural killer group 2
member D protein), perforin, or Fas-ligand (Figure 2a and b);
moreover, they exhibited an increased proliferation in vivo or
in vitro as evidenced by BrdU incorporation or re-stimulation
with HSV-1-loaded DCs, respectively (Figure 2c and d). It is
worth mentioning that CD8+ T cells expressing cytolytic
markers like granzyme A (gzmA) were also detectable at
increased numbers in lesional skin from K14-RANKL TG
versus WT mice (Figure 2e) and were located in close contact
to HSV-infected TUNEL+ cells (Supplementary Figure S4a
online), suggesting an upregulated cytolytic function of CD8+
T cells from K14-RANKL TG compared with WT mice. To
analyze the virus-speciﬁc cytolytic activity in more detail, we
performed in vitro cytotoxicity assays by co-culturing CD8+
T cells from lymph nodes draining cutaneous lesions of
HSV-1-infected TG and WT mice with cell tracker orange
-loaded MC57G target cells, which were previously primed
with the irrelevant antigen ovalbumin or whole HSV-1 protein
extract. Interestingly, CD8+ T cells from infected K14-RANKL
TG mice induced a signiﬁcantly increased lysis of HSV-1-
primed target cells as evidenced by the upregulated release of
the intracellular dye cell tracker orange compared with CD8+
T cells from WT controls (Figure 2f and g), demonstrating that
cutaneous RANK–RANKL signaling might indeed be involved
in the induction of virus-speciﬁc CTLs during HSV-1 infection.
To analyze the speciﬁc role of CD8+ T cells for antiviral
immunity in TG mice, we isolated CD8+ T cells from HSV-1-
infected WT or K14-RANKL TG donors, transferred them into
CD45.1+ congenic recipients, and infected recipient mice
with HSV-1. Although the adoptive transfer of CD8+ T cells
from WT donors resulted in a slight reduction in skin lesion
size, mice that were injected with CD8+ T cells from K14-
RANKL TG donors failed to develop inﬂammatory skin lesions
upon epicutaneous HSV-1 infection (Figure 3a). In line with
this, we detected elevated numbers of transferred CD8+
CD45.2+ cells in HSV-1 lesions from recipients of TG
compared with WT CD8+ T cells (Figure 3b), which
maintained the upregulated expression of cytolytic markers
such as NKG2D, Fas-L, or gzmB after adoptive cell transfer
(Supplementary Figure S4b online). It is worth mentioning that
the transfer of CD8+ T cells from naive or mock-infected K14-
RANKL TG donors did not protect recipient mice from
developing skin lesions upon HSV-1 infection (data not
shown). Next, we investigated whether CD8+ T cells are
indeed essential for the reduced severity of cutaneous HSV-1
infection in K14-RANKL TG mice in vivo. Therefore, CD8+
cells were depleted in WT and TG mice before infection using
speciﬁc antibodies (Supplementary Figure S4c online). Upon
HSV-1 infection CD8-depleted WT mice developed skin
lesions similar to those observed in mice treated with an IgG
control antibody, whereas CD8 depletion in K14-RANKL TG
mice led to a substantial increase in skin lesion size
(Figure 3c). In addition, CD8-depleted TG mice showed an
upregulated virus replication in lesional skin compared with
TG mice that received an IgG control (Figure 3d). Together,
these data show that cutaneous RANK–RANKL signaling is
critically involved in the induction of virus-speciﬁc CD8+
effector cells during HSV-1 infection of the skin.
RANK–RANKL-activated LCs are crucial for the induction of
antiviral CD8+ effector T cells
Upon HSV-1 infection of the skin, epidermal LCs are the ﬁrst
APC subset that comes into contact with the virus. However,
HSV infection can induce apoptosis of LCs, and, accordingly,
in WT mice, CD103+ dermal DCs but not LCs have been
identiﬁed as the main migratory APC able to transport viral
antigens from the site of infection to regional lymph nodes
(Bedoui et al., 2009; Puttur et al., 2010). As RANK–RANKL
signaling is known as a survival factor of T cells or immature
DCs (Cremer et al., 2002; Chen et al., 2004; So et al., 2006),
we speculated that activation via RANK–RANKL interactions
in TG skin might prevent HSV-1-induced LC apoptosis,
which, ﬁnally, could result in enhanced priming of CD8+
antiviral effector T cells. Interestingly, even 96 hours after
infection, LC apoptosis was signiﬁcantly reduced in K14-
RANKL TG compared with WT skin, as evidenced by staining
for annexin V or cleaved caspase-3 as well as TUNEL
(Figures 4a and b). Furthermore, LCs from TG skin expressed
upregulated levels of activating co-stimulatory markers like
CD86 and CD80 as well as pro-inﬂammatory cytokines, such
as IL-12 (Figure 4c), suggesting an increased viability of TG
compared with WT LCs after HSV-1 infection. This observa-
tion was further supported by immunoﬂuorescence staining
showing increased numbers of LCs downregulating E-cad-
herin and expressing the migration-associated marker CXCR4
in infected skin from TG compared with WT mice
(Supplementary Figure S5 online) pointing to an increased
migratory capacity of LCs from HSV-1-infected K14-RANKL
TG skin. To analyze whether RANK–RANKL-activated LCs
and their prolonged survival are crucial for the induction of
HSV-1-speciﬁc CD8+ effector T cells in vivo, we depleted LCs
from WT and TG skin using the Langerin-diphtheria-toxin-
receptor (Langerin-DTR) mouse model (Bennett et al., 2005).
Langerin-DTR as well as K14-RANKL TG mice bred onto a
Langerin-DTR background were injected with diphtheria
toxin to ablate LCs before HSV-1 infection (Supplementary
Figure S6 online). Notably, LC-depleted K14-RANKL TG mice
L Klenner et al.
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developed skin lesions similar to WT controls (Figure 4d). In
addition, LC ablation from TG skin led to an increased virus
replication as shown by the UL54 mRNA expression
(Figure 4e), and likewise impaired the expansion of CD8+
effector T cells (Figure 4f and g), thus indicating a critical role
of LCs for the induction of antiviral immunity in TG mice.
On the basis of its increased viability, LCs from HSV-1-
infected TG skin might have an improved capacity to transport
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viral antigens to regional lymph nodes or to transfer HSV-1
antigens to CD103+ migratory dermal DCs, resulting in
increased numbers of CD103+ DCs migrating from infected
skin to regional lymph nodes. Interestingly, we detected
elevated levels of CD207+ LCs co-expressing the marker
CD326, thus characterizing them as cells that emigrated from
the skin (Gaiser et al., 2012), in draining lymph nodes from
K14-RANKL TG compared with WT mice (Figure 5a). Of note,
the numbers of CD103+ dermal DCs that migrated from
cutaneous lesions to regional lymph nodes were similar in both
groups (Figure 5a). However, to clearly show that mainly LCs
contributed to the increased antiviral immune response in K14-
RANKL TG mice, additional experiments using mice speciﬁ-
cally lacking CD103+ dermal DCs (Honda et al., 2010; Ouchi
et al., 2011) are needed. In lymph nodes, draining HSV-1-
infected skin APCs coming from the site of infection transfer
viral antigens to lymph node–resident CD8α+ DCs, which in a
TLR3-dependent manner prime HSV-1-speciﬁc CTLs (Allan
et al., 2006; Bedoui et al., 2009; Eidsmo et al., 2009; Davey
et al., 2010). Flow cytometry and immunoﬂuorescence staining
revealed an increased expression of TLR3 in CD8α+ DCs from
regional lymph nodes of TG compared with WT mice, whereas
the total numbers of CD8α+ DCs were similar (Figure 5b and
c). Notably, LC ablation from K14-RANKL TG skin before
Figure 2. Increased numbers of cytotoxic T lymphocytes in HSV-1-infected K14-RANKL TG mice. (a and b) Representative dot plots (a) and statistical evaluation
(b) of cytolytic markers in CD8+ T cells from regional lymph nodes at day 8 post infection (n⩾3). (c) Representative dot plots and statistical evaluation of BrdU
incorporation in CD8+ T cells from regional lymph nodes at day 8 post infection (n=5). (d) Representative proliferation assay of CFSE-labeled CD8+ T cells from
regional lymph nodes of HSV-1- and mock-infected mice co-cultured with HSV-1-loaded DCs. Numbers of cell divisions are indicated. (e) Representative
immunoﬂuorescence staining and statistical evaluation of CD8+ T cells expressing granzyme A (gzmA) in HSV-1-infected skin at day 8 post infection (n=12;
original magniﬁcation × 400; bar = 20 μm; CD8+gzmA+ cells are highlighted by arrows). (f and g) Representative microscopy (f) and statistical evaluation (g) of
target cell lysis in cytotoxicity assays of CD8+ T cells from HSV-1- or mock-infected mice, co-cultured with cell tracker orange–labeled ovalbumin- or HSV-1-
loaded target cells (n⩾ 5 visual ﬁelds; bar=20 μm; lysed cells are highlighted). All the data are shown as mean± SEM; *, Po0.05 versus HSV-1-infected WT.
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Figure 3. Cutaneous RANK–RANKL signaling upregulates MHC class I-restricted antiviral immunity. (a and b) Adoptive transfer of CD8+ T cells from infected
CD45.2+ K14-RANKL TG and WT donors into naive CD45.1+ recipients (WT/TG→ CD45.1+) 1 day before HSV-1 infection of recipient mice. Mean skin lesion
size from n⩾6 mice per group is shown (a). (b) Representative immunoﬂuorescence staining and statistical evaluation of CD8+ and CD8+CD45.2+ cells in
lesional skin from HSV-1-infected recipient mice (n=3; original magniﬁcation × 400; bar = 50 μm; *Po0.05 versus WT→ CD45.1+). (c) Skin lesion size in WT
and K14-RANKL TG mice after depletion of CD8+ T cells before epicutaneous HSV-1 infection (n≥6). (d) Quantitative real-time PCR showing the UL54 (ICP27)
expression in lesional skin at day 8 post infection (p.i., n=4; *Po0.05 versus IgG control). All the data are shown as mean± SEM.
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HSV-1 infection reduced the expression of TLR3 in CD8α+
lymph node–resident DCs to WT level (Figure 5d), indicating
that RANK–RANKL-activated LCs are critically involved in the
regulation of TLR3 expression and thus in the CTL-priming
capacity of CD8α+ DCs. In support of this K14-RANKL TG
mice on a TLR3− /− background showed a similar disease
progression after HSV-1 infection as compared with TLR3− /−
controls (Figure 5e). Moreover, in the absence of TLR3, the
expression of cytolytic markers in CD8+ T cells from HSV-1-
infected K14-RANKL TG mice was normalized to WT level
(Figure 5f).
Soluble RANKL protects WT mice from HSV-1 infection by
inducing CD8+ antiviral effector T cells
Having shown that in K14-RANKL TG mice cutaneous
RANK–RANKL signaling is crucial for the induction of
antiviral CD8+ effector T cells by protecting LCs from
HSV-1-induced apoptosis and upregulating TLR3 in CD8α+
lymph node–resident DCs, we intended to investigate
whether soluble RANKL protein might be sufﬁcient to induce
protective MHC class I-restricted antiviral immunity in WT
mice. Interestingly, the local treatment of WT mice with
recombinant RANKL protein at day 2 and 4 after HSV-1
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challenge led to a reduced disease severity, as shown by the
signiﬁcantly downregulated skin lesion size and viral replica-
tion compared with phosphate-buffered saline-treated con-
trols (Figure 6a and b). Importantly, this was associated with a
decreased annexin V exposition on the cell surface of
epidermal CD207+ LCs, an upregulated TLR3 expression in
lymph node–resident CD8α+ DCs (Figure 6d), and ﬁnally with
the priming of CD8+ effector T cells expressing cytotoxic
markers, such as Eomes, KLRG1, or NKG2D (Figure 6e–f),
although the total number of CD8+ T cells in regional lymph
nodes was not altered by local RANKL treatment (Figure 6e).
Together, these data demonstrate that cutaneous RANK–
RANKL signaling is critically involved in the induction of
antiviral CD8+ effector T cells during HSV-1 infection of the
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skin by preventing virus-induced LC apoptosis and improving
the CTL priming capacity of CD8α+ lymph node–resident DCs
by upregulating TLR3.
DISCUSSION
Here, we demonstrated that cutaneous RANK–RANKL signal-
ing is critically involved in the priming of antiviral CD8+
effector T cells during HSV-1 infection of the skin. This effect
was initiated by the prevention of LC apoptosis resulting in an
enhanced migration of LCs to regional lymph nodes and an
improved induction of HSV-1-speciﬁc antiviral immunity,
which was dependent on TLR3 signaling.
In vivo, the induction of virus-speciﬁc CD8+ effector T cells
can be controlled by immunosuppressive Tregs (Rouse and
Suvas, 2007; Lund et al., 2008), and RANK–RANKL signaling
mediates the peripheral expansion of these cells (Loser et al.,
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2006; Loser and Beissert, 2009, 2012). Upon cutaneous
HSV-1 infection, K14-RANKL TG mice showed reduced
disease severity as compared with WT controls, possibly
suggesting that the infection might have impaired the RANKL-
mediated expansion of functional Treg. This hypothesis was
supported by studies demonstrating that, during infection,
Tregs frequently lose their suppressive activity in response to
upregulated TLR signaling (Dasgupta et al., 2001; Peng et al.,
2005; Zhang et al., 2010; Hackl et al., 2011). However,
although we detected increased levels of various TLRs, such
as TLR2, TLR7, and TLR9, in infected skin from TG mice
(Klenner, unpublished observation), in vitro suppression
assays revealed that Tregs from HSV-1-infected WT and TG
mice inhibited the proliferation of effector T cells equally
well, indicating that a potential loss of Treg function has a
minor role in explaining the reduced disease severity in
HSV-1-infected K14-RANKL TG mice.
In contrast, our data suggested that RANK–RANKL interac-
tions might have directly contributed to the induction of MHC
class I–restricted antiviral immunity. In agreement with our
observations, co-administration of RANKL in Trypanosoma
cruzi or inﬂuenza infection of mice markedly enhanced the
induction of antigen-speciﬁc CD8+ effector T cells (Miyahira
et al., 2003), suggesting a general immunostimulatory role of
RANKL in CD8+ T cell-mediated immunity against infection.
Of note, this effect was highly speciﬁc to RANK–RANKL
signaling as the administration of CD40L, a closely related
ligand within the TNF-TNF receptor family, did not result in
increased CTL priming (Miyahira et al., 2003). In support of
this, in a cell culture system, it has been shown that co-
expression of RANK and RANKL in T cells, but not CD40 and
CD40L, augmented the IFN-γ secretion as well as the
expansion of CTLs (Wiethe et al., 2003). In addition, also in
human cells signaling via RANK–RANKL was shown to
expand virus-speciﬁc CTL responses when added alone or
in combination with other TNF family molecules (Yu et al.,
2003). However, the immunostimulatory effect of RANK–
RANKL signaling during infection does not seem to be
restricted to CD8-mediated immunity, as in lymphocytic
choriomeningitis virus infection RANK–RANKL interactions
provided co-stimulatory signals required for the priming of
antiviral CD4+ T cells (Bachmann et al., 1999). These data, in
combination with the result of our study, indicate that, in
addition to an inﬂammatory microenvironment induced by
viral infections, co-stimulation provided by the TNF-TNF
receptor pair RANK–RANKL is essential to elicit efﬁcient
priming of antiviral effector T cells.
The priming of virus-speciﬁc effector T cells requires
antigen uptake by localized DCs and the subsequent antigen
transport to regional lymph nodes (Bedoui and Greyer, 2014).
In the skin, LCs are the obvious primary DC subset likely to be
initially involved in HSV-1 antigen uptake, and, accordingly,
earlier analyses on the role of LCs in anti-HSV-1 immunity
claimed that depletion of LCs before infection leads to
increased HSV-1 virulence (Sprecher and Becker, 1986).
However, more recently, several studies have conclusively
shown that in WT mice, LCs are not the cells presenting
HSV-1 antigens to CD8+ T cells and thus are not directly
involved in the induction of MHC class I-restricted antiviral
immune responses (Allan et al., 2006; Cunningham et al.,
2008; Bedoui et al., 2009; Eidsmo et al., 2009; Puttur et al.,
2010). After epicutaneous HSV-1 infection, lymph node–
resident CD8α+ DCs or migratory CD103+ dermal DCs were
identiﬁed to be the predominant DC population presenting
HSV-1 antigens to CD8+ T cells (Allan et al., 2006; Bedoui
et al., 2009). Of note, these data imply that skin-acquired
HSV-1 antigens are transferred from LCs to other DC subsets,
in which the antigen transfer from one DC subtype to another
might act as ampliﬁer of antiviral immunity (Allan et al., 2006;
Bedoui and Greyer, 2014). In HSV-1-infected K14-RANKL TG
mice, antiviral immune responses were enhanced compared
with WT controls, which was initiated by an increased
viability and migratory capacity of LCs. Even 4 days after
HSV-1 infection, we detected almost 100% viable LCs in
infected skin from TG mice, whereas approximately half of
the cells fromWT skin expressed cleaved caspase-3 or stained
positive for TUNEL. It is well accepted that HSV-1 infection
induces apoptosis in mouse as well as human DC subsets or
impedes DC migration as the virus was shown to reduce anti-
apoptotic transcripts (Kather et al., 2010) or to inhibit the
downregulation of E-cadherin, which is an important
prerequisite for DC migration to regional lymph nodes after
antigen uptake (Cunningham et al., 2010; Puttur et al., 2010).
Both, inducing apoptosis in DC subsets at the site of infection
and preventing the efﬁcient antigen transport to draining
lymph nodes, might represent an escape mechanism of the
virus by which it reduces the priming of antiviral effector
T cells. Our data suggest that RANK–RANKL signaling, by
protecting LCs from HSV-1-induced apoptosis and increasing
their migratory capacity (we observed an upregulated
expression of the migration-associated marker CXCR4 in
cutaneous DCs from TG compared with WT mice, and,
moreover, in TG skin, the HSV-1-mediated prevention of
E-cadherin downregulation seemed to be less pronounced;
Supplementary Figure S5 online), could represent a mechan-
ism counteracting the reduction of antiviral immunity induced
by the virus. This hypothesis became evident in the improved
priming of HSV-1-speciﬁc CD8+ T cells in infected TG
compared with WT mice, whereas further experiments—for
instance, using mice speciﬁcally lacking migratory CD103+
dermal DCs (Honda et al., 2010; Ouchi et al., 2011)—are
needed to elucidate the contribution of other DC subsets than
LCs to the improved antiviral immune response in K14-
RANKL TG mice. In HSV-1 infection efﬁcient CTL priming is
known require to TLR3 signaling (Davey et al., 2010). In line
with these data, we observed an upregulated expression of
TLR3 in CD8α+ lymph node–resident DCs from TG compared
with WT lymph nodes, which interestingly was not detectable
in TG mice lacking LCs, thus again pointing to a role of LCs in
the modulation of the CTL priming capacity of lymph node–
resident DCs. Importantly, the injection of soluble RANKL
protein into lesional skin was sufﬁcient to induce viable, fully
mature LCs, which migrated to regional lymph nodes and
upregulated TLR3 expression in CD8α+ lymph node–resident
DCs, resulting in the amelioration of ongoing HSV-1 infection
by activating and expanding antiviral CD8+ effector T cells.
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Thus, our data suggest a potential therapeutic relevance of
RANKL in the protection against HSV-1 infection. However,
as the consequences of RANKL deletion in keratinocytes on
the expansion of HSV-1-speciﬁc CD8+ effector T cells and
MHC class I–mediated antiviral immunity have not been
investigated so far, one cannot conclude that RANKL is
essential in mediating immunity against HSV-1. Furthermore,
blocking RANKL signaling in K14-RANKL TG mice by using
the speciﬁc antagonist RANK-Fc might be necessary to assess
whether the effects observed in HSV-1-infected TG mice are
indeed speciﬁc to RANKL rather than additional signals that
upon infection might occur in TG keratinocytes and result in
improved LC survival.
MATERIALS AND METHODS
Mice
K14-RANKL transgenic (TG) mice on a C57BL/6 background (Loser
et al., 2006), C57BL/6 WT, CD45.1 congenic mice (Charles River,
Sulzfeld, Germany), RAG1− /− mice (The Jackson Laboratory, Bar
Harbor, ME), TLR3− /− mice (The Jackson Laboratory), and Langerin-
DTR mice (Bennett et al., 2005) were used at the ages of 8–12 weeks
and housed under speciﬁc pathogen-free conditions in micro-isolator
cages. Mice were given chow and water ad libitum and were
monitored for clinical symptoms and weighed daily. All animal
experiments were performed with the approval of the State Review
Board of North Rhine-Westphalia (Germany) according to the
German law for animal welfare (Tierschutzgesetz) §8, reference
number 8.87-50.10.36.08.004.
HSV-1 infection
Herpes simplex virus type 1, Glasgow strain 17syn+ (HSV-1), was
grown in minimal essential medium (Merck Millipore, Darmstadt,
Germany) supplemented with 10% fetal bovine serum and titrated on
Vero cells. Virus titer was quantiﬁed by plaque assay as described
(Hafezi et al., 2002). Unless stated otherwise, mice were
epicutaneously infected at the shaved, depilated, and scratched
back skin of the upper right ﬂank proximal to the dorsal midline with
2× 107 plaque-forming units. Skin lesion size at the primary site (site
of infection) and the secondary site (site of viral spread from the
ganglia due to zosteriform expansion) was quantiﬁed daily using a
digital caliper (Mitutoyo, Neuss, Germany). The lower left ﬂank was
scratched as well and topically treated with an equal volume of
minimal essential medium instead of HSV-1 (referred to as mock-
infected contralateral skin).
Cytotoxicity assay
CD8+ T cells were puriﬁed by magnetic cell separation
(Miltenyi, Bergisch Gladbach, Germany) from draining lymph nodes
at day 8 post infection and co-cultured with MC57G target cells that
have been loaded with CellTracker orange (Life Technologies) and
primed with either 1 μgml−1 ovalbumin protein or 1 μg ml−1 HSV-1
protein extract for 3 hours at 37 °C (ratio effector to target
cells= 1:100). Lysis of target cells was analyzed by ﬂow cytometry
and microscopy after 16 hours of co-culture. As a positive or negative
control, target cells were treated with 2% Triton X-100 or phosphate-
buffered saline for 2 hours.
Adoptive cell transfers
At day 8 post infection, lymph nodes draining cutaneous lesions were
isolated from donor mice on a CD45.2+ background, and CD8+
T cells were puriﬁed by magnetic cell separation (Miltenyi).
Subsequently, 20× 106 CD8+CD45.2+ T cells were injected intrave-
nously into naive congenic CD45.1+ recipients, and 24 hours later,
recipient mice were epicutaneously infected with HSV-1.
Depletion of CD8+ T cells or LCs
CD8+ T cells were depleted by intravenous injection of 50 μg anti-
CD8 (clone YTS 169) per mouse at day-8 and day-2. At day 1, the
depletion of CD8+ T cells was veriﬁed by ﬂow cytometry of peripheral
blood cells. Controls received an equal amount of a rat IgG control
antibody (BD, Heidelberg, Germany).
For the depletion of LCs, Langerin-DTR mice (Bennett et al., 2005)
were injected intraperitoneally with 400 ng of diphtheria toxin
(Merck Millipore) at day-3 and day-5. Control groups were treated
with phosphate-buffered saline instead of diphtheria toxin.
Injection of soluble RANKL protein
In some experiments, WT mice were injected subcutaneously with
1 μg recombinant RANKL protein (BioLegend) at day 2 and day 4
after HSV-1 infection. Control groups were treated with an equal
amount of phosphate-buffered saline.
CONFLICT OF INTEREST
The authors state no conﬂict of interest.
ACKNOWLEDGMENTS
We thank Markus M. Simon, Max-Planck-Institute for Immunobiology and
Epigenetics, for providing the anti-granzyme A antibody as well as Marie-Luise
Romberg, Meike Steinert, and Kerstin Vischedyk for excellent technical
assistance. This study was supported by the German Research Foundation
(DFG, projects LO817/5-1 and SFB 1009 TP B07 to KL) as well as by the
Interdisciplinary Center for Clinical Research (IZKF, project Lo2/004/11 to KL).
Author contributions
LK performed most of the experiments; WH ampliﬁed and provided virus
stocks and conducted the HSV-1 infection of keratinocytes; EUL designed and
provided HSV-1-speciﬁc primers; BEC generated and provided Langerin-DTR
mice; TAL and SB contributed advice in parts of the study; JEK contributed
expertise and helped to analyze data; KL conceived the study, analyzed the
data, and wrote the paper.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Allan RS, Smith CM, Belz GT et al. (2003) Epidermal viral immunity induced by
CD8alpha+ dendritic cells but not by Langerhans cells. Science 301:
1925–8
Allan RS, Waithman J, Bedoui S et al. (2006) Migratory dendritic cells transfer
antigen to a lymph node-resident dendritic cell population for efﬁcient CTL
priming. Immunity 25:153–62
Bachmann MF, Wong BR, Josien R et al. (1999) TRANCE, a tumor necrosis
factor family member critical for CD40 ligand-independent T helper cell
activation. J Exp Med 189:1025–31
Bedoui S, Greyer M (2014) The role of dendritic cells in immunity against
primary herpes simplex virus infections. Front Microbiol 5:533
L Klenner et al.
RANKL Upregulates MHC-Class I-Restricted Antiviral Immunity
2686 Journal of Investigative Dermatology (2015), Volume 135
Bedoui S, Whitney PG, Waithman J et al. (2009) Cross-presentation of viral and
self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 10:
488–95
Belkaid Y, Piccirillo CA, Mendez S et al. (2002) CD4+CD25+ regulatory T cells
control leishmania major persistence and immunity. Nature 420:502–7
Bennett CL, van Rijn E, Jung S et al. (2005) Inducible ablation of mouse
langerhans cells diminishes but fails to abrogate contact hypersensitivity. J
Cell Biol 169:569–76
Bosnjak L, Miranda-Saksena M, Koelle DM et al. (2005) Herpes simplex virus
infection of human dendritic cells induces apoptosis and allows cross-
presentation via uninfected dendritic cells. J Immunol 174:2220–7
Chen A, Xu H, Choi Y et al. (2004) TRANCE counteracts FasL-mediated
apoptosis of murine bone marrow-derived dendritic cells. Cell Immunol
231:40–8
Cremer I, Dieu-Nosjean MC, Maréchal S et al. (2002) Long-lived immature
dendritic cells mediated by TRANCE-RANK interaction. Blood 100:
3646–55
Cunningham AL, Carbone F, Geijtenbeek TB (2008) Langerhans cells and viral
immunity. Eur J Immunol 38:2377–85
Cunningham AL, Abendroth A, Jones C et al. (2010) Viruses and
Langerhans cells. Immunol Cell Biol 88:416–23
Dasgupta G, Chentouﬁ AA, You S et al. (2001) Engagement of TLR2 reverses the
suppressor function of conjunctiva CD4+CD25+ regulatory T cells and
promotes herpes simplex virus epitope-speciﬁc CD4+CD25- effector T cell
responses. Invest Ophthalmol Vis Sci 52:3321–33
Davey GM, Wojtasiak M, Proietto AI et al. (2010) Cutting edge: Priming of CD8
T cell immunity to herpes simplex virus type 1 requires cognate TLR3
expression in vivo. J Immunol 184:2243–6
Egan KP, Wu S, Wigdahl B et al. (2013) Immunological control of herpes
simplex virus infections. J Neurovirol 19:328–45
Eidsmo L, Allan R, Caminschi I et al. (2009) Differential migration of epidermal
and dermal dendritic cells during skin infection. J Immunol 182:3165–72
Gaiser MR, Lämmermann T, Feng X et al. (2012) Cancer-associated epithelial
cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans
cell motility and migration in vivo. Proc Natl Acad Sci USA 109:E889–97
Hafezi W, Eing BR, Lorentzen EU et al. (2002) Reciprocal transmission of herpes
simplex virus type 1 (HSV-1) between corneal epithelium and trigeminal
neurites in an embryonic chick organ culture. FASEB J 16:878–80
Hackl D, Loschko J, Sparwasser T et al. (2011) Activation of dendritic cells via
TLR7 reduces Foxp3 expression and suppressive function in induced tregs.
Eur J Immunol 41:1334–43
Honda T, Nakajima S, Egawa G et al. (2010) Compensatory role of Langerhans
cells and langerin-positive dermal dendritic cells in the sensitization phase
of murine contact hypersensitivity. J Allergy Clin Immunol 125:1154–6
Kather A, Raftery MJ, Devi-Rao G et al. (2010) Herpes simplex virus type 1
(HSV-1)-induced apoptosis in human dendritic cells as a result of
downregulation of cellular FLICE-inhibitory protein and reduced expres-
sion of HSV-1 antiapoptotic latency-associated transcript sequences. J Virol
84:1034–46
Loser K, Beissert S (2012) Regulatory T cells: banned cells for decades. J Invest
Dermatol 132:864–71
Loser K, Beissert S (2009) Regulation of cutaneous immunity by the
environment: an important role for UV irradiation and vitamin D. Int
Immunopharmacol 9:587–9
Loser K, Mehling A, Loeser S et al. (2006) Epidermal RANKL controls regulatory
T-cell numbers via activation of dendritic cells. Nat Med 12:1372–9
Lund JM, Hsing L, Pham TT et al. (2008) Coordination of early protective
immunity to viral infection by regulatory T cells. Science 320:1220–4
Miyahira Y, Akiba H, Katae M et al. (2003) Cutting edge: A potent adjuvant
effect of ligand to receptor activator of NF-kappa B gene for inducing
antigen-speciﬁc CD8+ T cell response by DNA and viral vector
vaccination. J Immunol 171:6344–8
Nandakumar S, Woolard SN, Yuan D et al. (2008) Natural killer cells as novel
helpers in anti-herpes simplex virus immune response. J Virol 82:10820–31
Ouchi T, Kubo A, Yokouchi M et al. (2011) Langerhans cell antigen capture
through tight junctions confers preemptive immunity in experimental
staphylococcal scalded skin syndrome. J Exp Med 208:2607–13
Peng G, Guo Z, Kiniwa Y et al. (2005) Toll-like receptor 8-mediated reversal of
CD4+ regulatory T cell function. Science 309:1380–4
Petermann P, Thier K, Rahn E et al. (2015) Entry mechanisms of herpes simplex
virus 1 into murine epidermis: involvement of nectin-1 and herpesvirus
entry mediator as cellular receptors. J Virol 89:262–74
Puttur FK, Fernandez MA, White R et al. (2010) Herpes simplex virus infects skin
gamma delta T cells before Langerhans cells and impedes migration of
infected langerhans cells by inducing apoptosis and blocking E-cadherin
downregulation. J Immunol 185:477–87
Roizman B, Whitley RJ (2013) An inquiry into the molecular basis of HSV
latency and reactivation. Annu Rev Microbiol 67:355–74
Rouse BT, Suvas S (2007) Regulatory T cells and immunity to pathogens. Expert
Opin Biol Ther 7:1301–9
Salameh S, Sheth U, Shukla D (2012) Early events in herpes simplex virus
lifecycle with implications for an infection of lifetime. Open Virol J 6:1–6
Sandri-Goldin RM (2011) The many roles of the highly interactive HSV protein
ICP27, a key regulator of infection. Future Microbiol 6:1261–77
So T, Lee SW, Croft M (2006) Tumor necrosis factor/tumor necrosis factor
receptor family members that positively regulate immunity. Int J Hematol
83:1–11
Sprecher E, Becker Y (1986) Skin langerhans cells play an essential role in the
defense against HSV-1 infection. Arch Virol 91:341–9
van Lint A, Ayers M, Brooks AG et al. (2004) Herpes simplex virus-speciﬁc
CD8+ T cells can clear established lytic infections from skin and nerves
and can partially limit the early spread of virus after cutaneous inoculation.
J Immunol 172:392–7
Werner S, Grose R (2003) Regulation of wound healing by growth factors and
cytokines. Physiol Rev 83:835–70
Wiethe C, Dittmar K, Doan T et al. (2003) Enhanced effector and memory CTL
responses generated by incorporation of receptor activator of NF-kappa B
(RANK)/RANK ligand costimulatory molecules into dendritic cell immuno-
gens expressing a human tumor-speciﬁc antigen. J Immunol 171:4121–30
Wojtasiak M, Pickett DL, Tate MD et al. (2010) Gr-1+ cells, but not neutrophils,
limit virus replication and lesion development following ﬂank infection of
mice with herpes simplex virus type-1. Virology 407:143–51
Yu Q, Gu JX, Kovacs C et al. (2003) Cooperation of TNF family members CD40
ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the
activation of dendritic cells and the expansion of viral speciﬁc CD8+ T cell
memory responses in HIV-1-infected and HIV-1-uninfected individuals. J
Immunol 170:1797–805
Zhang Y, Lian JQ, Huang CX et al. (2010) Overexpression of toll-like receptor
2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory
T cells in chronic hepatitis B virus infection. Virology 397:34–42
Zhu J, Peng T, Johnston C et al. (2013) Immune surveillance by CD8αα+ skin
resident T cells in human herpes virus infection. Nature 497:494–7
L Klenner et al.
RANKL Upregulates MHC-Class I-Restricted Antiviral Immunity
www.jidonline.org 2687
